These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 3342405

  • 1. Loss of metastatic responsiveness to cell shape modulation in a newly characterized B16 melanoma adhesive cell variant.
    Nabi IR, Raz A.
    Cancer Res; 1988 Mar 01; 48(5):1258-64. PubMed ID: 3342405
    [Abstract] [Full Text] [Related]

  • 2. Effects of tertiary amine local anesthetics on the blood-borne implantation and cell surface properties of metastatic mouse melanoma cells.
    Nicolson GL, Fidler IJ, Poste G.
    J Natl Cancer Inst; 1986 Mar 01; 76(3):511-9. PubMed ID: 3456465
    [Abstract] [Full Text] [Related]

  • 3. Expression of tumor antigen correlated with metastatic potential of Lewis lung carcinoma and B16 melanoma clones in mice.
    Falcioni R, Kennel SJ, Giacomini P, Zupi G, Sacchi A.
    Cancer Res; 1986 Nov 01; 46(11):5772-8. PubMed ID: 3756921
    [Abstract] [Full Text] [Related]

  • 4. Differential expression of a Mr approximately 90,000 cell surface transferrin receptor-related glycoprotein on murine B16 metastatic melanoma sublines selected for enhanced brain or ovary colonization.
    Nicolson GL, Inoue T, Van Pelt CS, Cavanaugh PG.
    Cancer Res; 1990 Feb 01; 50(3):515-20. PubMed ID: 2297694
    [Abstract] [Full Text] [Related]

  • 5. Effects of tunicamycin on B16 metastatic melanoma cell surface glycoproteins and blood-borne arrest and survival properties.
    Irimura T, Gonzalez R, Nicolson GL.
    Cancer Res; 1981 Sep 01; 41(9 Pt 1):3411-8. PubMed ID: 7260906
    [Abstract] [Full Text] [Related]

  • 6. Alpha-melanocyte-stimulating hormone blocks invasion of reconstituted basement membrane (Matrigel) by murine B16 melanoma cells.
    Murata J, Ayukawa K, Ogasawara M, Fujii H, Saiki I.
    Invasion Metastasis; 1997 Sep 01; 17(2):82-93. PubMed ID: 9561027
    [Abstract] [Full Text] [Related]

  • 7. Metastatic potential of murine B16 melanoma correlates with reduced surface heparan sulfate glycosaminoglycan.
    Kure S, Yoshie O, Aso H.
    Jpn J Cancer Res; 1987 Nov 01; 78(11):1238-45. PubMed ID: 2961717
    [Abstract] [Full Text] [Related]

  • 8. Low colony formation in vivo and in culture as exhibited by metastatic melanoma cells selected for reduced homotypic aggregation.
    Lotan R, Raz A.
    Cancer Res; 1983 May 01; 43(5):2088-93. PubMed ID: 6187442
    [Abstract] [Full Text] [Related]

  • 9. Extraction of immunogenic and suppressogenic antigens from variants of B16 melanoma exhibiting low or high metastatic potentials.
    LeGrue SJ, Hearn DR.
    Cancer Res; 1983 Nov 01; 43(11):5106-11. PubMed ID: 6616449
    [Abstract] [Full Text] [Related]

  • 10. The selection and characterization of an invasive variant of the B16 melanoma.
    Hart IR.
    Am J Pathol; 1979 Dec 01; 97(3):587-600. PubMed ID: 507192
    [Abstract] [Full Text] [Related]

  • 11. Differences in cytotoxic effects of activated murine peritoneal macrophages and J774 monocytic cells on metastatic variants of B16 melanoma.
    Miner KM, Klostergaard J, Granger GA, Nicolson GL.
    J Natl Cancer Inst; 1983 Apr 01; 70(4):717-24. PubMed ID: 6339778
    [Abstract] [Full Text] [Related]

  • 12. Epigenetic transfer of metastatic activity by uptake of highly metastatic B16 melanoma cell-released exosomes.
    Hao S, Ye Z, Li F, Meng Q, Qureshi M, Yang J, Xiang J.
    Exp Oncol; 2006 Jun 01; 28(2):126-31. PubMed ID: 16837903
    [Abstract] [Full Text] [Related]

  • 13. Relationship between the organization and synthesis of vimentin and the metastatic capability of B16 melanoma cells.
    Ben-Ze'ev A, Raz A.
    Cancer Res; 1985 Jun 01; 45(6):2632-41. PubMed ID: 4039222
    [Abstract] [Full Text] [Related]

  • 14. The relationship between motility factor receptor internalization and the lung colonization capacity of murine melanoma cells.
    Watanabe H, Nabi IR, Raz A.
    Cancer Res; 1991 May 15; 51(10):2699-705. PubMed ID: 2021948
    [Abstract] [Full Text] [Related]

  • 15. Metastatic potential and multidrug resistance correlation in the B16 melanoma system.
    Staroselsky AN, Mahlin T, Savion N, Klein O, Nordenberg J, Donin N, Michowitz M, Leibovici J.
    J Exp Ther Oncol; 1996 Jul 15; 1(4):251-9. PubMed ID: 9414412
    [Abstract] [Full Text] [Related]

  • 16. Comparative study of sialidase activity and G(M3) content in B16 melanoma variants with different metastatic potential.
    Sawada M, Moriya S, Shineha R, Satomi S, Miyagi T.
    Acta Biochim Pol; 1998 Jul 15; 45(2):343-9. PubMed ID: 9821865
    [Abstract] [Full Text] [Related]

  • 17. Selection of malignant melanoma variant cell lines for ovary colonization.
    Brunson KW, Nicolson GL.
    J Supramol Struct; 1979 Jul 15; 11(4):517-28. PubMed ID: 544929
    [Abstract] [Full Text] [Related]

  • 18. Identification of B16-F1 melanoma autocrine motility-like factor receptor.
    Nabi IR, Watanabe H, Raz A.
    Cancer Res; 1990 Jan 15; 50(2):409-14. PubMed ID: 2153051
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of radiation-enhanced expression of integrin and metastatic potential in B16 melanoma cells by a lipoxygenase inhibitor.
    Onoda JM, Kantak SS, Piechocki MP, Awad W, Chea R, Liu B, Honn KV.
    Radiat Res; 1994 Dec 15; 140(3):410-8. PubMed ID: 7972695
    [Abstract] [Full Text] [Related]

  • 20. The role of glycoconjugates in metastatic melanoma blood-borne arrest and cell surface properties.
    Irimura T, Nicolson GL.
    J Supramol Struct Cell Biochem; 1981 Dec 15; 17(4):325-36. PubMed ID: 7328676
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.